APA (7th ed.) Citation

Manegold, C. (2017). Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy. ESMO open, 1(6), . https://doi.org/10.1136/esmoopen-2016-000118

Chicago Style (17th ed.) Citation

Manegold, Christian. "Novel Active Agents in Patients with Advanced NSCLC Without Driver Mutations Who Have Progressed After First-line Chemotherapy." ESMO Open 1, no. 6 (2017). https://doi.org/10.1136/esmoopen-2016-000118.

MLA (9th ed.) Citation

Manegold, Christian. "Novel Active Agents in Patients with Advanced NSCLC Without Driver Mutations Who Have Progressed After First-line Chemotherapy." ESMO Open, vol. 1, no. 6, 2017, https://doi.org/10.1136/esmoopen-2016-000118.